Funding · Company
Interius BioTherapeutics, Inc.
Philadelphia, PABiotech & Pharma
Interius BioTherapeutics, Inc. of Philadelphia, PA has disclosed $73M across 2 Form D offerings filed with the SEC between Oct 20, 2023 and Jun 3, 2024.
$73M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$51M
Form D · Jun 3, 2024 ↗
Q2 2024
· target $83M
Filing details
HeadquartersPhiladelphia, PAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001807811Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →